Targeting non-coding RNAs to overcome cancer therapy resistance

BQ Chen, MP Dragomir, C Yang, Q Li, D Horst… - Signal transduction and …, 2022 - nature.com
It is now well known that non-coding RNAs (ncRNAs), rather than protein-coding transcripts,
are the preponderant RNA transcripts. NcRNAs, particularly microRNAs (miRNAs), long non …

Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer

H Liu, C Lei, Q He, Z Pan, D **ao, Y Tao - Molecular cancer, 2018 - Springer
MicroRNAs (miRNAs) are endogenous non-coding RNAs that contain approximately 22
nucleotides. They serve as key regulators in various biological processes and their …

Targeting RNA in mammalian systems with small molecules

A Donlic, AE Hargrove - Wiley Interdisciplinary Reviews: RNA, 2018 - Wiley Online Library
The recognition of RNA functions beyond canonical protein synthesis has challenged the
central dogma of molecular biology. Indeed, RNA is now known to directly regulate many …

Nuclear miRNAs: gene regulation activities

M Billi, E De Marinis, M Gentile, C Nervi… - International Journal of …, 2024 - mdpi.com
MicroRNAs (miRNAs) are small non-coding RNAs which contribute to the regulation of many
physiological and pathological processes. Conventionally, miRNAs perform their activity in …

[HTML][HTML] The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease management

VR Ramnarine, M Kobelev, EA Gibb, M Nouri, D Lin… - European urology, 2019 - Elsevier
Context It is increasingly evident that non–protein-coding regions of the genome can give
rise to transcripts that form functional layers of the cancer genome. One of most abundant …

Boosting RNAi therapy for orthotopic glioblastoma with nontoxic brain-targeting chimaeric polymersomes

Y Shi, Y Jiang, J Cao, W Yang, J Zhang, F Meng… - Journal of controlled …, 2018 - Elsevier
Glioblastoma with intracranial infiltrative growth remains an incurable disease mainly owing
to existence of blood brain barrier (BBB) and off-target drug toxicity. RNA interference (RNAi) …

[PDF][PDF] Long non-coding RNA and Polycomb: an intricate partnership in cancer biology

C Achour, F Aguilo - Front. Biosci, 2018 - venus-pro-bucket.s3.amazonaws …
2106 Long non-coding RNA and Polycomb: an intricate partnership in cancer biology Cyrinne
Achour1, 2, Francesca Aguilo1, 2 1Wall Page 1 2106 Long non-coding RNA and Polycomb: an …

Functional impact of non-coding RNAs in high-grade breast carcinoma: Moving from resistance to clinical applications: A comprehensive review

A Jaiswal, N Kaushik, EH Choi, NK Kaushik - Biochimica et Biophysica Acta …, 2023 - Elsevier
Despite the recent advances in cancer therapy, triple-negative breast cancers (TNBCs) are
the most relapsing cancer sub-type. It is partly due to their propensity to develop resistance …

MicroRNAs: immune modulators in cancer immunotherapy

Y **ng, Z Wang, Z Lu, J **a, Z **e, M Jiao… - Immunotherapy …, 2021 - academic.oup.com
MicroRNA (miRNA) is a class of endogenous small non-coding RNA of 18–25 nucleotides
and plays regulatory roles in both physiological and pathological processes. Emerging …

The Wnt-pathway corepressor TLE3 interacts with the histone methyltransferase KMT1A to inhibit differentiation in Rhabdomyosarcoma

B Kalita, S Sahu, A Bharadwaj, L Panneerselvam… - Oncogene, 2024 - nature.com
Rhabdomyosarcoma tumor cells resemble differentiating skeletal muscle cells, which unlike
normal muscle cells, fail to undergo terminal differentiation, underlying their proliferative and …